Immunomodulating Drugs in the Management of Psoriatic Arthritis

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.2, Iss.6, 2001-06, pp. : 367-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psoriatic Arthritis: Recognition and Management

By Bruce I.N. Gladman D.D.

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Etanercept: A Review of its Use in the Management of Plaque Psoriasis and Psoriatic Arthritis

By Goldsmith David R. Wagstaff Antona J.

American Journal of Clinical Dermatology, Vol. 6, Iss. 2, 2005-01 ,pp. : 121-136

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Rheumatoid Arthritis This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in Drugs 2002; 62 (17): 2493-2537.

By Culy C.R. Keating G.M.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 139-145

Adis International

Access to resources Recommend Favorite

The Potential of Newer Immunomodulating Drugs in the Treatment of Uveitis: A Review

By Salzmann J. Lightman S.

BioDrugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 397-408

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Plaque Psoriasis and Psoriatic Arthritis

By Goldsmith David R. Wagstaff Antona J.

BioDrugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 401-403

Adis International

Access to resources Recommend Favorite